Document is current
Any future updates will be listed below
-
Authors
Nabbi, Arash
Beck, Pengbo
Delaidelli, Alberto
Oldridge, Derek A.
Sudhaman, Sumedha
Zhu, Kelsey
Yang, S. Y. Cindy
Mulder, David T.
Bruce, Jeffrey P.
Paulson, Joseph N.
Raman, Pichai
Zhu, Yuankun
Resnick, Adam C.
Sorensen, Poul H.
Sill, Martin
Brabetz, Sebastian
Lambo, Sander
Malkin, David
Johann, Pascal D.
Kool, Marcel
Jones, David T. W.
Pfister, Stefan M.
Jäger, Natalie
Pugh, Trevor J. https://orcid.org/0000-0002-8073-5888
-
Funding
Funding for this research was provided by:
Terry Fox Research Institute
NHLBI Division of Intramural Research
Parker Institute for Cancer Immunotherapy
Deutsche Krebshilfe
- License Information
-
More Information
Article History
Received: 24 October 2022
Accepted: 7 August 2023
First Online: 7 September 2023
Declarations
:
: The Research Ethics Board at University Health Network (UHN REB) approved this study (CAPCR/REB number 18–5248). All participants provided written informed consent to participate as well as to use and share data for the study. The UHN REB operates in compliance with the Tri-Council Policy Statement, ICH Guideline for Good Clinical Practice E6 (R1), Ontario Personal Health Information Protection Act (2004), Part C Division 5 of the Food and Drug Regulations, and Part 4 of the Natural Health Products Regulations and the Medical Devices Regulations of Health Canada. This research conformed to the Declaration of Helsinki.
: All participant information was anonymized and informed consent for publication is obtained for all datasets.
: J.N.P is an employee of Genentech, Inc. (Stock and Other Ownership Interests: F. Hoffmann-La Roche AG). The remaining authors declare that they have no competing interests.
